• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Stem Cell Research News


  • Please log in to reply
337 replies to this topic

#271 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 01 February 2005 - 05:17 AM

Embryo Stem Cells Coaxed into "Movement" Nerves
Creation of motor neurons could lead to new treatments for spinal cord injuries and nervous system diseases


Betterhumans Staff
1/31/2005 2:04 PM
http://www.betterhum...ID=2005-01-31-3


Embryo Stem Cells Coaxed into "Movement" Nerves
Creation of motor neurons could lead to new treatments for spinal cord injuries and nervous system diseases
Betterhumans Staff
1/31/2005 2:04 PM


Human embryonic stem cells have been coaxed into motor neurons that relay messages from the brain to the rest of the body.

The work is a step towards using embryonic stem cell-derived motor neurons to treat such conditions as spinal cord injuries and nervous system diseases such as Lou Gehrig's.

While such treatments may be many years away, the advance could sooner allow researchers to create motor neuron modeling systems to screen new drugs, says study leader Su-Chun Zhang of the University of Wisconsin-Madison.

Timely cocktails

Motor neurons communicate messages from the brain and spinal cord to allow movement in the body.

While embryonic stem cells can replicate indefinitely and become any of the body's 220 different types of cells and tissues, coaxing them into motor neurons has been difficult, says Zhang.

There is a narrow time frame in which such a conversion can occur, and the cells must be exposed to a number of complex chemical cocktails.

"You need to teach the [embryonic stem cells] to change step by step, where each step has different conditions and a strict window of time," says Zhang.

Stages of growth

To differentiate embryonic stem cells into functional motor neurons, Zhang and colleagues took them through different stages, each requiring unique growing mediums and precise timing.

They began by generating neural stem cells. These were transformed into progenitor cells of motor neurons. These were then transformed into motor neuron cells in a lab dish.

Zhang says that the motor neurons exhibit electrical activity that indicates they are functional.

They have also survived in culture in the lab for more than three months.

The next step for the researchers is to test if the neurons can communicate with one another in a living animal. They will start with chicken embryos.

The research is reported in the journal Nature Biotechnology (read abstract).

Is this a bit of good news for stephen hawkings?

#272 Chip

  • Guest
  • 387 posts
  • 0

Posted 01 February 2005 - 06:02 AM

Wow, them cells, them cells gonna rise again.

I don't think Bush is really doing it out of some moralistic reasoning. From some history I got from some lectures I downloaded concerning Naziism, I find that though Hitler personally confided in a few that he thought religion was an abomination, he still embraced Christianity in public and the rise of the Nazi party was painted as a rise of the Christian right. I understand Karl Rove first presented the idea that Georgie Porgie could benefit politically by at least seeming to cater to religious fundamentals and then shortly thereafter Bush became a born again. It was after that Bush was caught flipping the bird to staff members when he thought the camera wasn't running. I got a copy of the video somewhere. I haven't met a true Christian fundamentalist who would do that. No, I think he's just pretending to embrace the controversial fundamentalist agenda for political ends. Of course, surrounding himself with lies and living lies are liable to bring him to believe in some of those lies sometimes. It is really a crazy scene here in the states. i'm afraid its going to get worst before it gets better.

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#273 Mind

  • Life Member, Director, Moderator, Treasurer
  • 19,070 posts
  • 2,000
  • Location:Wausau, WI

Posted 06 February 2005 - 01:08 PM

Spleen may be source of versatile stem cells

"There may be a previously undiscovered pocket of primitive stem cells in the spleen that are important for healing several types of damage or injury," says Denise Faustman, MD, PhD, director of the MGH Immunobiology Laboratory and senior author of the SAGE KE report. "If so, these cells could have much broader therapeutic applications than suggested by our earlier work."

In 2001 Faustman's team found that a treatment designed to address the autoimmune reaction underlying type 1 diabetes actually cured the disease in diabetic mice. Late in 2003 they reported the mechanism behind the earlier discovery: cells from the spleens of donor mice - intended to train the diabetic animals' immune systems not to attack islet cells - were actually producing new islets. The result suggested that the adult spleen - previously regarded as playing a fairly minor role in regenerative medicine - might contain a population of potential islet stem cells.

In their pursuit of that finding, the MGH researchers investigated the possible presence of a protein called Hox11 in these cells. In mammals, Hox11 is a controller of key steps in embryonic development - including the formation of the spleen - but it was not known to be present in adults under normal circumstances. In some other animals, however, the protein has an intriguing function: when creatures like newts regenerate a lost limb or tail, production of Hox11 is radically increased.

As reported in their SAGE KE article, the MGH team did find that Hox11 was produced in the spleens of adult mice by the same cells that regenerated the islets in the earlier study. They also found that these cells did not produce a protein known to be associated with a cellular commitment to develop into a particular type of tissue. Without that commitment, the splenic cells may be able to differentiate into a wider variety of cells than can adult stem cells from bone marrow, which do not produce Hox11.

The researchers also note that the spleen develops from embryonic tissue that is known not only to generate precursors to many types of blood cells, a function shared by the bone marrow, but potentially to form such diverse organs as the small intestine, uterus, vascular system and lung. They theorize that a pocket of these uncommitted cells might remain in the spleen though adulthood. In addition to regeneration of islets, these cells might also produce bone cells - suggested by findings from other researchers - or potentially even cells of the nervous system, development of which depends on the correct production of Hox11.



sponsored ad

  • Advert

#274 Lazarus Long

  • Life Member, Guardian
  • 8,116 posts
  • 242
  • Location:Northern, Western Hemisphere of Earth, Usually of late, New York

Posted 06 February 2005 - 06:43 PM

Yellow alert!

We have trouble in River City ladies and gentlemen. Yessiree real trouble.

This case promises to enter the debate in a big way, whichever way the ultimate decision goes.

http://story.news.ya..._embryo_lawsuit
Couple May Sue Over Discarded Embryo
Sat Feb 5,10:15 PM ET U.S. National - AP

CHICAGO - A couple whose frozen embryo was accidentally destroyed at a fertility clinic has the right in Illinois to file a wrongful-death lawsuit, a judge has ruled in a case that some legal experts say could have implications in the debate over embryonic stem cell research.

In an opinion issued Friday, Cook County Judge Jeffrey Lawrence said "a pre-embryo is a 'human being' ... whether or not it is implanted in its mother's womb."

He said the couple is as entitled to seek compensation as any parents whose child has been killed.

The suit was filed by Alison Miller and Todd Parrish, who stored nine embryos in January 2000 at the Center for Human Reproduction in Chicago. Their doctor said one embryo looked particularly promising, but the Chicago couple were told six months later the embryos had been accidentally discarded.

In his ruling, Lawrence relied on the state's Wrongful Death Act, which allows lawsuits to be filed if unborn fetuses are killed in an accident or assault. "The state of gestation or development of a human being" does not preclude taking legal action, the act says.

Lawrence also cited an Illinois state law that says an "unborn child is a human being from the time of conception and is, therefore, a legal person."

"There is no doubt in the mind of the Illinois Legislature when life begins," Lawrence wrote.

Another judge had thrown out the couple's wrongful-death claims, but Lawrence reversed that decision, partly because that judge did not explain his decision at the time.

An attorney for the fertility clinic said an appeal would likely be filed.

The decision could curb reproductive research, said Colleen Connell, executive director of the American Civil Liberties Union (news - web sites) in Chicago.

Connell expects the ruling will be overturned on appeal.

"It may be groundbreaking, but it's the wrong decision," Connell said. "No appellate court has ever declared a fertilized egg a human being in a wrongful-death suit."

Stem cells can potentially grow into any type of human tissue. Many scientists believe they could someday be used to repair spinal cord injuries and treat some diseases. Anti-abortion groups oppose such research because it involves destroying embryos, and the Bush administration has severely restricted federal stem cell funding.

Abortion opponents praised Lawrence's ruling. "Life begins at fertilization, not implantation," Pro-Life Action League director Joe Scheidler said.

While the ruling likely is too narrow to affect abortion law, it increases legal risks for fertility clinics, said John Mayoue, a family attorney in Atlanta and specialist on in-vitro law.

Mayoue said court rulings on the treatment of embryos have been contradictory.

"We are considering embryos to be property for certain purposes and life for others, and that's the incongruity," he said.

#275 Michael

  • Advisor, Moderator
  • 1,293 posts
  • 1,792
  • Location:Location Location

Posted 18 February 2005 - 04:54 AM

All:

Holy shit!

This should make us all very optimistic about the possibility of rejuvenating our native stem cell populations, and alleviate concerns about the need for appropriate signaling networks to guide the development of stem cells in stem cell-based therapies, as raised by eg Pete Estep.

----------------

Rejuvenation of aged progenitor cells by exposure to a young systemic environment
IRINA M. CONBOY, MICHAEL J. CONBOY, AMY J. WAGERS, ERIC R. GIRMA, IRVING L. WEISSMAN & THOMAS A. RANDO
Nature 433, 760 - 764 (17 February 2005); doi:10.1038/nature03260

The decline of tissue regenerative potential is a hallmark of ageing and may be due to age-related changes in tissue-specific stem cells1-5. A decline in skeletal muscle stem cell (satellite cell) activity due to a loss of Notch signalling results in impaired regeneration of aged muscle1, 6. The decline in hepatic progenitor cell proliferation owing to the formation of a complex involving cEBP- and the chromatin remodelling factor brahma (Brm) inhibits the regenerative capacity of aged liver7. To examine the influence of systemic factors on aged progenitor cells from these tissues, we established ... a shared circulatory system between young and old mice ..., exposing old mice to factors present in young serum. Notably, [this] restored the activation of Notch signalling as well as the proliferation and regenerative capacity of aged satellite cells. The exposure of satellite cells from old mice to young serum enhanced the expression of the Notch ligand (Delta), increased Notch activation, and enhanced proliferation in vitro. Furthermore, heterochronic parabiosis increased aged hepatocyte proliferation and restored the cEBP- complex to levels seen in young animals. These results suggest that the age-related decline of progenitor cell activity can be modulated by systemic factors that change with age.

Ageing of metazoans can be generally characterized as a progressive decline of tissue and organ function, accompanied by increased oxidative damage8, mitochondrial dysfunction9, endocrine imbalance10 and genome instability11. Tissue regenerative capacity also declines with age, and in tissues such as muscle, blood, liver and brain this decline has been attributed to a diminished responsiveness of tissue-specific stem and progenitor cells1, 3-5.

...

Our experiments suggest that there are systemic factors that can modulate the molecular signalling pathways critical to the activation of tissue-specific progenitor cells, and that the systemic environment of a young animal is one that promotes successful regeneration, whereas that of an older animal either fails to promote or actively inhibits successful tissue regeneration. It will be of great interest to identify the factors that have such a critical influence on tissue-specific progenitor cells. Our studies also demonstrate that the decline of tissue regenerative potential with age can be reversed through the modulation of systemic factors, suggesting that tissue-specific stem and progenitor cells retain much of their intrinsic proliferative potential even when old, but that age-related changes in the systemic environment and niche in which progenitor cells reside preclude full activation of these cells for productive tissue regeneration.

-----------
http://www.wired.com...4,66615,00.html

Young Blood Makes Muscles Spry
By Kristen Philipkoski

10:00 AM Feb. 16, 2005 PT

Researchers at Stanford University have found that an infusion of young blood has significant benefits.

It's not a figure of speech. The scientists linked the blood supply of young mice to old mice, and what they found will have an impact on stem-cell research as well as the scientific study of aging: The young blood activated stem cells in the old muscles that allowed them to recover from injury like a spring chicken.

....the results, published in the Feb. 17 issue of Nature, are exciting for stem-cell researchers and tissue-regeneration scientists looking for therapies in everything from elderly care to spinal-cord injury.

"It's not so much about making people live longer," said Dr. Thomas Rando, associate professor of neurology at Stanford University School of Medicine. "But if some older person gets a broken bone or skin wound, maybe we could improve their recovery rate. Maybe there's a chance to enhance the potential of old tissues."

If you're thinking a blood transfusion will offer the same effects, think again. The old mice shared their younger counterparts' blood supply for six weeks."

---------------

-Michael

#276 kevin

  • Member, Guardian
  • 2,779 posts
  • 822

Posted 19 February 2005 - 10:12 PM

Link: http://www.innovatio...port-40592.html


Scientists rid stem cell culture of key animal cells

Posted Image
Caption: This image depicts a colony of human embryonic stem cells grown over a period of 10 months in the absence of mouse feeder cells. The cell nuclei are stained green; the cell surface appears in red. Photo: courtesy Ren-He Xu
Tackling a pressing and controversial technical barrier in stem cell biology, scientists at the WiCell Research Institute and the University of Wisconsin-Madison have crafted a recipe that allows researchers to grow human embryonic stem cells in the absence of mouse-derived "feeder" cells, long thought to be a source of potential contamination for the therapeutically promising cells.

The new findings, appear today (Feb. 17) in the journal Nature Methods and come on the heels of a recent University of California study showing that existing stem cell lines are already contaminated with an animal molecule. The potential threat of animal pathogens tainting human stem cell lines poses a problem for the safe clinical use of many, if not all, of the current cell lines now in use.

Until now, scientists have had to grow and sustain stem cells through the tedious daily task of generating mouse feeder cells from mouse embryos. Feeder cells, or fibroblasts, are connective tissue cells that form the matrix upon which stem cells grow.

The mouse feeder cells were an important ingredient in the mix of culture materials required to keep stem cells in their undifferentiated "blank slate" state. Embryonic stem cells are capable of forming any of the 220 tissues and cells in the human body and, in culture, are constantly trying to migrate down different developmental pathways. Maintaining stock cultures in their undifferentiated state is critical.

The feeder cell dogma now can be overturned, says lead investigator Ren-He Xu, a senior scientist at WiCell, a private, nonprofit research institute. "This work completely gets rid of the need for feeder cells," says Xu. "It also significantly reduces the daily labor of preparing the feeder cell-conditioned medium."

"It is important that the culture of human ES cells be simplified so that the average scientist can use them without extensive prior training," says James Thomson, a UW-Madison professor of anatomy and a co-author of the Nature Methods paper. "This development is a good step in that direction. Also, clinically, the feeder cells were one of the main sources of potential contamination with pathogens, so their elimination should improve safety. However, not all the animal components have been removed from the media yet, but this is an important step."

Working with three of WiCell’s five human embryonic stem cell lines, Xu and his team explored the molecular interactions within the stem cell growth medium. He discovered that, in certain conditions, a protein known as fibroblast growth factor 2 (FGF2) accomplishes the same critical role that feeder cells are thought to play: ensuring that the stem cells remain in their undifferentiated state and capable of proliferation.

"We’ve got it down to the mechanism," Xu says.

Moreover, Xu made the surprising discovery that the very molecules that encourage human embryonic stem cells to differentiate appear to inhibit differentiation in mouse embryonic stem cells.

Aside from feeder cells, two other sources of animal material remain in stem cell culture materials. One, Matrigel, is a product that is essentially a plate-coating matrix of cells extracted from mouse tumors. Serum replacement, which is bovine in origin, is the other animal material still needed to culture stem cells.

Xu became interested in unveiling molecules derived from the mouse feeder cells because, in their absence, stem cells start to differentiate within two to three days. Xu started by evaluating the effect of changing stem cell growth conditions - using less feeder cell material, or no serum replacement, for instance.

Unexpectedly, Xu found that the presence of serum replacement promoted stem cell differentiation. Digging deeper, he found that serum replacement mimics the activity of bone morphogenetic protein (BMP), a molecule known to kick-start embryonic development, or in this case, cell differentiation.

If serum replacement triggers stem cell differentiation, Xu deduced, there must be feeder cell molecules that oppose BMP activity. Experiments confirmed this to be true.

Next, Xu elevated concentrations of FGF2, a protein routinely used for human embryonic stem cell culture, to test whether FGF2 preserves undifferentiated stem cells in the absence of BMP. The result was that "the cells looked perfect." Xu says he has grown the resulting stem cells in the desired undifferentiated state for almost a year.

Although the new work "dramatically reduces the possibility of contamination" from animal pathogens, Xu warns that the continued use of serum replacement and Matrigel means that contamination remains a concern. The ultimate goal, he says, would be to culture stem cells in media completely free of any animal products.

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#277 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 21 February 2005 - 09:03 PM

U.N. Calls for Clone Ban

http://www.wired.com...tw=wn_tophead_2

Washington D.C. -- The United Nations has called on countries to ban all forms of human cloning "incompatable with human dignity." The American religious right claims victory, but others say the declaration is the result of political maneuvering influenced by pressure from the United States.

The politicization of science policy in the United States has become a contentious issue in the past several years, with groups like the Union of Concerned Scientists criticizing the Bush administration for favoring political interests over scientific results. Now, that trend seems to be making international inroads.

Nations including Singapore, South Korea, Belgium and the United Kingdom blasted the declaration by the divided U.N. committee, calling it political posturing.

American scientists did their own blasting here on Sunday. Organizers of the annual meeting of the American Association for the Advancement of Science devoted nine hours of seminars plus a press conference to what they say is increasing influence of political interests on science policy. Politics in America, they say, have inappropriately influenced not only stem cell research and cloning science, but also reports on climate change, endangered species policies, fisheries energy and many others.

"In the scientific community in other countries we are ridiculed," said Kurt Gottfried, chairman of the Union of Concerned Scientists, in an interview. "It has certainly lowered our prestige across the world."

U.S. delegates to the United Nations supported a treaty to ban all cloning starting in 2002. After nearly two years of negotiations, the U.N. shelved attempts to agree on a treaty and instead delegates opposed to cloning pushed for a non-binding declaration as a compromise.

Cloning bills in the United States have languished in Congress for years for the same reasons the United Nations could not agree on a ban: Legislators have been unwilling to separate therapeutic cloning (also known as somatic cell nuclear transfer) from reproductive human cloning, which would produce a baby who is a genetic copy of an adult.

Researchers want to use cloned human embryos to develop disease-specific stem cell lines that could teach them how to interfere with the progress of diseases, or to create cell therapies.

Social conservatives and the anti-abortion lobby have championed a ban on therapeutic cloning because early embryos are destroyed in the process. In September, President Bush told the United nations that a complete cloning ban was one of his top priorities. And in late October, the U.N. postponed a cloning vote until after the United States' Nov. 2 elections.

"Some scientists are working for a way around the objections, but I don t think it's very likely they'll find one," said Donald Kennedy, editor-in-chief of the journal Science. "I think it would be much more appropriate for the federal government to relax the declaration of August 9, 2001," when president Bush said no federal money going forward would go toward stem cell research that destroyed embryos.

The United States is becoming notorious in the eyes of other countries, Gottfried said, as a nation that has allowed ideology to become a premise for science. That perception is sure to have harmful repercussions on the American science community, he said. Scientists are already leaving the country and graduate students are less uninterested in studying in the United States, he said.

When government agencies allow special interests to overshadow science in policy making, the credibility and influence of the agencies themselves are undermined, Gottfried said during a seminar.

"The real danger is that these agencies could be harmed in the long run," he said. "This is an oversight issue and Congress should really be handling it."


I wish BUSH would just go away! He is seriously holding back really good science that could help millions of people. Although Stem cell research will go ahead in other countries, Funding will be far less than what the states could put into it.

#278 Lazarus Long

  • Life Member, Guardian
  • 8,116 posts
  • 242
  • Location:Northern, Western Hemisphere of Earth, Usually of late, New York

Posted 14 March 2005 - 03:34 AM

Another front in the battle for longer life is being engaged and the medical community is beginning to stand up. They are saying safe science is all well and good but sometimes those who are dying deserve the right to take calculated risks that may offer us all more hope as well.


http://www.nytimes.c...artner=homepage
The Uncertain Science of Growing Heart Cells
By NICHOLAS WADE
Published: March 14, 2005

In April 2001, researchers from the New York Medical College and the National Institutes of Health announced electrifying news for heart surgeons and their patients: stem cells from bone marrow, injected into the damaged hearts of mice, had morphed into the special cardiac muscle cells that the body cannot replace after a heart attack.

The researchers held out the hope the procedure could be applied to people, too. The findings underlined a basic premise of stem cell therapy, that it will work before the cells and their elaborate control systems are fully understood - just put stem cells in the right place in the body, and they will do the rest. But four years later, the treatment has yet to demonstrate whether it will fulfill its promise. And it has touched off a sharp difference of views among clinical doctors as to whether the therapy is ready to be taken to people.

Ten human trials of the marrow-to-heart approach have now been completed in clinics around the world, all but one with positive results. But the overall degree of improvement in the patients' heart function has been modest. At the same time, the original research that provided the rationale for many of the trials has come under severe criticism from scientists who have tried without success to reproduce it.

The approach, if it works, would be a leading example of regenerative medicine, the idea that the best way to repair the body is not with strong drugs or the surgeon's scalpel but with the body's own system of cells and signaling molecules. Regenerative medicine should work, in principle, on the host of diseases that result as aging organs and tissues fail to maintain the vigor of youth.

The difficulties of the marrow-to-heart therapy do not dash the hopes for regenerative medicine or imply failure for the stem cell research financing set up by states like California and New Jersey. But they do suggest that successful stem cell treatments, whether with adult cells or ones derived from embryos, may require many years to come to fruition.

The bone marrow stem cell technique, devised by Dr. Donald Orlic of the National Institutes of Health and Dr. Piero Anversa of New York Medical College in Valhalla, N.Y., was taken up with such alacrity because it promised to address a desperate medical need and seemed reasonably safe, given that patients were to be injected with their own cells. Patients are now being recruited for at least two trials in the United States, one at the Texas Heart Institute in Houston and a second at the Caritas St. Elizabeth's Medical Center in Boston and two other sites.

The Houston trial, led by Dr. James T. Willerson and Dr. Emerson C. Perin, follows from a test in Dr. Perin's native Brazil. Though Brazilian regulators would allow only the sickest patients to be enrolled, Dr. Perin said, there was "significant evidence" that the treatment worked. Before receiving injections of their bone marrow stem cells, most of the patients were bedridden or too sick to walk without effort. But after treatment, he said, "some patients were jogging on the beach, one climbed eight flights of stairs, and one, who had gone home to live with his mother, reopened his business."

On the strength of these results, the Food and Drug Administration allowed the Texas Heart Institute to start recruiting patients for a similar trial. So far 13 patients with end-stage coronary disease have been treated, and all are doing well. "We are thrilled by what we have seen," Dr. Willerson said of the two trials.

At the St. Elizabeth's Medical Center, Dr. Douglas W. Losordo has started recruiting patients and is also impressed with the results so far.

"There are dramatic examples of patients' going from being bedbound to living normal lives," Dr. Losordo said. Although the study is blind, meaning he does not know which patients were treated and which are serving as controls, the group as a whole is doing better. One patient who has left the study - the rules allow patients showing no response to be withdrawn after six months - turned out to be in the untreated group.

But though clinicians say they are encouraged, researchers are considerably more skeptical. At least two separate laboratories, at Stanford University and at the University of Washington in Seattle, reported last year that they had been unable to repeat the Orlic-Anversa experiment. Bone marrow stem cells, these researchers found, did not turn into heart tissue. The few that lodged in the heart turned into blood cells in the usual way. The Stanford researchers, who included Dr. Irving Weissman, a leading expert on the blood's stem cells, warned that until the science underlying the clinical trials was better understood, "these studies are premature and may in fact place a group of sick patients at risk."

Clinicians have paid little heed to this apparent setback, arguing that there is an urgent need to try anything that is safe and might do good, regardless of whether its mechanism of action is fully understood.

"The basic-science guys don't see patients that are going to die, but I have to look them in the face every day," Dr. Perin said. "It's ludicrous to say we must understand the molecular mechanisms before we can try anything."

Dr. Losordo said, "My patients and I have finite lifespans, and adult stem cells to me are an answer that is available in the very near term."


Clinicians say they have established that the technique is safe - some 200 patients have now been treated worldwide without adverse effect - and that the results so far are worth pursuing. But individual cases, however striking, count less than overall statistics. Most studies so far show a 5 percent to 10 percent improvement in heart function. While not great, that is not discouraging either, given that most of the patients were very sick to begin with.

A degree of improvement this mild could be caused by some unintended aspect of the treatment. Just the act of injecting the heart can cause local inflammation, leading perhaps to better circulation in the inflamed area. While that possibility has not been ruled out, the clinicians are convinced that something in the potent mix of bone marrow stem cells is causing the results they see. Dr. Helmut Drexler, leader of a clinical trial in Hannover, Germany, said last year that if the bone marrow stem cells were failing to convert into heart cells themselves, as the critics assert, perhaps the cells were secreting hormones that prompted a beneficial response from the heart's own cells.

Clinicians like the Texas and Tufts teams carry out their own laboratory research and are hoping to discover which of the several different kinds of stem cells in the bone marrow is the most effective. Dr. Losordo and his colleague Dr. Young-sup Yoon reported this year that they had isolated a special kind of bone marrow stem cell that in laboratory tests can morph into each of the three kinds of cell that build the heart. This or some other specific stem cell could be a better agent to inject than crude bone marrow extracts, but the clinicians have not yet agreed on a better candidate.

Meanwhile, basic researchers are trying to figure out the natural role of stem cells in maintaining the heart. Dr. Anversa has long championed the belief that the heart does possess the ability to generate new muscle cells, despite its apparent inability to do so after a heart attack. Four years ago he described evidence that the heart's muscle cells can divide, contradicting the dogma that no new heart cells are created after birth.

But if the heart does possess stem cells, their role seems confined to slowly replacing the heart's muscle cells throughout life, and does not include emergency repairs after a heart attack.

"You are not supposed to live long enough to get a heart attack," said Dr. Kenneth Chien, a research cardiologist at the University of California, San Diego.

The bone marrow may be a source of stem cells for repairing organs in crisis, including the heart. Even if so, this system, too, fails to operate when needed. Some researchers say they think the stem cell system itself may age and lose its effectiveness in older people. If so, it could be futile to treat elderly patients with their own stem cells, sharply limiting the possibilities of the new therapy.

"In older individuals, perhaps the regenerative capacity of the stem cell pool is compromised," said Dr. Mark Sussman of San Diego State University. Dr. Sussman hopes to enhance the cells' vigor by lengthening their telomeres, segments of DNA that shorten each time a cell divides and limit how often it can do so.

A quite different approach is being explored by Dr. Silviu Itescu of Columbia University. In Dr. Itescu's view, not only may a patient's own bone marrow cells be compromised by age, but bone marrow transplants are far too expensive for a commonly required operation. That argues for finding a generic source of younger cells that can be used to treat any patient.

Four years ago, Dr. Itescu and his colleagues found a bone marrow stem cell that caused proliferation in the heart of the tiniest blood vessels, known as capillaries. Though that seemed promising at the time, Dr. Itescu did not proceed to clinical trials, saying the improvement was too small. He says he has now found a more promising type of bone marrow stem cell that increases the arterioles, blood vessels one size up from capillaries.

Meanwhile, Dr. Anversa has repeated his original experiment with the same results as before. In an article in the journal Circulation Research, he suggested that his critics had failed to follow his procedure correctly and suffered from "emotional disbelief" - fighting words for a scientific article - that bone marrow cells were capable of morphing into heart cells. He believes that the new bone marrow stem cells discovered by the Tufts team may be the source of the new cells he sees in damaged hearts.

Some researchers say the clinicians, by using a crude extract of bone marrow cells, will find it hard to figure out which kind of stem cell, if any, is having the beneficial effect. "We are spending a lot of time on clinical trials that are unlikely to give us definitive answers because the science has not caught up yet," Dr. Itescu said.

But the researchers acknowledge they cannot yet advise the clinicians which kind of stem cell is the best candidate for heart repair. "The literature is replete with contradictions that have generated widespread confusion," Dr. Orlic said. Dr. Sussman called the situation a "quagmire."

Perhaps not surprising, the two groups have differing views about the likely time scale for bone marrow stem cells to become standard therapy for ailing hearts.

"There is mounting evidence that these cells have therapeutic potency," Dr. Losordo said. "In the near term, within three to five years, this therapy will be available to treat a large population of patients with a very common disease."

But researchers fear that the clinicians, in their desire to offer something immediately to patients who have run out of options, are being too hasty. "Let's find the right cell first," Dr. Chien said. The clinicians complain that will take years, he said, adding: "They are right. It will take years."



#279 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 29 March 2005 - 02:40 AM

Hair is good source of stem cells

US scientists say they found a good source of stem cells - hair follicles.
The fact that hair grows quickly and is continually replenished makes it an attractive source to harvest the amount of stem cells needed for treatments.

This has been a major stumbling block of stem cell research, as well as controversy surrounding the ethics of harvesting cells from embryos.

The Proceedings of the National Academy of Science study shows nerve cells can be grown from hair follicle stem cells.

Stem cells are immature cells that have the ability to become any kind of tissue in the body.

Hair grows from follicles and new follicle cells are born from stem cells that exist in a small bulge on the side of the hair follicle.

Researchers from the University of Pennsylvania have already suggested that these stem cells might be a way of treating baldness.

Now Dr Yasuyuki Amoh and colleagues from the University of California, San Diego, have shown that the same stem cells could potentially be used to treat neurological conditions.

They found that the follicle stem cells from the whiskers of mice expressed a substance called nestin, a known signal to tell cells to develop into neurons.

They then tested whether the follicle cells could develop into mature nerve cells and found that they could when they were transplanted under the skin of the mice.

The follicle stem cells were also able to grow into skin cells, smooth muscle cells and pigment-producing cells called melanocytes.

"These results suggests that hair follicle stem cells may provide an accessible source of stem cells for therapeutic application," said the researchers.

Dr Robin Lovell-Badge, head of the division of developmental genetics at the Medical Research Council's National Institute for Medical Research, said: "It's definitely a source of cells that needs to be explored.

"We want to find the best source of cells possible."

He said it would be important to compare the quality of hair follicle stem cells with stem cells derived from other sources.

He said follicle stem cells did carry the bonus of being relatively accessible.

Source: http://news.bbc.co.u...lth/4378941.stm

#280 walpurg

  • Guest
  • 26 posts
  • 0

Posted 11 April 2005 - 03:24 PM

http://wired.com/new...6,67155,00.html

Lop off a newt's leg or tail, and it will grow a new one. The creature's cells can regenerate thanks to built-in time machines that revert cells to early versions of themselves in a process called dedifferentiation.

Researchers who study this mechanism hope one day to learn how to induce the same "cell time travel" in humans. If the cells go back far enough, they become stem cells, which researchers believe hold promise for treating many diseases. Stem cells, which are often taken from embryos, are unformed and have the ability to become many different types of cells. If researchers succeed in inducing this cell time travel, they will also eliminate the ethical issues surrounding embryonic stem-cell research, because no embryos would be destroyed to obtain the cells.

#281 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 13 April 2005 - 05:46 PM

Breakthrough in stem cell research13 April 2005


In an Australian first, UNSW researchers have developed three clones of cells from existing human embryonic stem cells. The breakthrough could lead to new treatments for conditions such as diabetes, Parkinson's disease and spinal cord injury.

"This cloning of cells involves a new technique, which is a very accurate way of extracting and then growing a single cell," said UNSW Senior Lecturer Dr Kuldip Sidhu, who is leading the research and is based at the Diabetes Transplant Unit (DTU) at the Prince of Wales Hospital, a major teaching hospital of UNSW. "There has only been one report of cloning of cells from human embryonic stem cells anywhere else in the world - in Israel."

By growing a human stem cell colony from a single cell, researchers are one step closer to deriving a homogenous population of cells of a particular type.

"There are about 230 different cell types in the body. All these cells are derived from three embryonic layers - one which forms the brain and spinal cord, another which forms the guts and liver and a third which forms muscles and bones," he said. "We need to establish a recipe to derive each of these from human embryonic stem cells, so they can be transplanted straight into the affected area of a patient.

"The insulin-producing cells, which are derived from the layer which also forms the gut and liver are the holy grail for diabetes researchers," said Dr Sidhu. "That's because they are destroyed in type-1 diabetes, which affects at least 100,000 people in Australia. So far there is no cure for it.

"Human embryonic stem cell research offers a permanent answer to the problem. It gives the hope that we can produce a pure population of those cells in large numbers and transplant them into the patient."

The researchers are currently in the discovery phase, where they are trying to characterise the three clonal lines they have developed.

"It is too early to say anything about these clonal lines, but one of them is inclined towards the cells which form the guts and liver," said Dr Sidhu.

Dr Sidhu and Professor Bernie Tuch, the Director of DTU have received a grant for US$140,000 for two years from the Juvenile Diabetes Research Foundation (JDRF) in the United States to continue their work.

The research comes as the Federal government's moratorium limiting the use of excess embryos ends.

Contact details: Susi Hamilton, UNSW Media Unit, tel 9385 1583 or 0422 934 024; Charles Maddison, Public Affairs Director, Prince of Wales Hospital, tel 0405 121 805

Date Issued: 13 April 2005

http://www.unsw.edu....Stem_cells.html

#282 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 29 April 2005 - 12:16 AM

Pioneering stem-cell surgery restores sight

April 29, 2005

PIONEERING form of surgery has been developed that can restore the sight of patients by using stem cells to encourage damaged eyes to repair themselves.
A team of British specialists has successfully treated more than a dozen patients with impaired corneas by transplanting human stem cells grown in a laboratory on to their eyes.

Recent operations on ten patients showed that the technique restored sight in seven cases of people who had been blinded after getting acid, alkali and boiling metal in their eyes, or because of congenital disorders.

Many of the patients treated at the Centre for Sight, Queen Victoria Hospital, in East Grinstead, West Sussex, had been told that they had no hope of getting their sight back, or had already undergone failed corneal transplants.

The process involves taking stem cells, which occur naturally in the eye, and developing them into sheets of cells in the laboratory. These are transplanted on to the surface of the eye where they are held in place by an amniotic membrane, which dissolves away as the sheet fuses to the eye.

Sheraz Daya, an ophthalmic surgeon leading the Sussex team, which has spent five years perfecting the technique, said that doctors had been astonished at how the cells appeared to trigger the eye’s natural regeneration of its damaged surface. Tests on the patients after a year revealed no trace of the DNA of the stem-cell donor, meaning that the repair was carried out by the eye’s own cells — a permanent healing process that does not require long-term use of powerful drugs to suppress the patient’s immune system.

Mr Daya said: “The technique not only works, but there was no donor tissue there. That is what really blew our minds. The cells appeared to have been shed from the eye and replaced by the patient’s own, much more hardy, cells.”

The team, including scientists at the hospital’s McIndoe Surgical Centre, now hopes to identify the processes at work, which might then be used to trigger the repair of other damaged tissue around the body. Details of the trial were revealed this month at an international conference of eye specialists in America. All the patients in the trial had corneas that had become damaged because they no longer had limbal stem cells, which are normally under the eyelid and help to keep the surface of the cornea clear, protecting it.

Edward Bailey, who lost his sight after caustic acid landed in his left eye while he was cleaning pipes at a yoghurt factory, said that the operation had transformed his life.

“It was the most emotional moment,” Mr Bailey, 65, said. “I couldn’t believe it. For ten years all I had seen was shades of black and grey, then after I had the operation the nurse came by and I saw a flash of blue from her uniform. I went home and when I took the patch off my eye, I had my vision back. It is only when you lose something like sight that you realise how precious it is.”

Nadey Hakim, a consultant surgeon at St Mary’s Hospital, London, said that it was likely that such action could be mimicked in other organs, thus reducing the need for organ transplants. Professor Hakim said: “The hope is that stem cells will one day be used to generate large quantities of cells and tissues and possibly entire organs damaged by disease and injury. It is a dream.”


After a person is blinded, you may get someone saying... Well you are going to be blinded for life and its the same with many other cases in diseases. Some believe that we will never fix these sort of problems. Over the past few years Ive seen many predictions saying that Blindness and deafness will be cured within 20 years possibly... But looking at all the advances that are happening and a rapid rate I might add.. It just seems like we are so close to solving these problems and they could be used widely within the next 5-10 years.

So people should be careful when they say. you will have that disease for the rest of your life. When if you are young, its likely that diseases you have may be fixed in the near future.

#283 Lazarus Long

  • Life Member, Guardian
  • 8,116 posts
  • 242
  • Location:Northern, Western Hemisphere of Earth, Usually of late, New York

Posted 19 May 2005 - 11:11 PM

With comments from our old bioconservative friends ;))

It appears the South Koreans just aren't getting the memos. [wis]

http://www.nytimes.c...artner=homepage
South Koreans Streamline Cloning of Human Embryos
By GINA KOLATA
NY Times Published: May 19, 2005
In what scientists say is a stunning leap forward, a team of South Korean researchers has developed a highly efficient recipe for producing human embryos by cloning and then extracting their stem cells.

Writing today in the journal Science, they report that they used their method to produce 11 human stem cells lines that are genetic matches of patients aged 2 to 56.

Previously, the same group, led by Dr. Woo Suk Hwang and Dr. Shin Yong Moon of Seoul National University, produced a single stem cell line from a cloned embryo, but the process was so onerous that scientists said it was not worth trying to repeat it, and some doubted the South Koreans' report was even correct.

Now things have changed.

"It is a tremendous advance," said Dr. Leonard Zon, a stem cell researcher at Harvard Medical School and president of the International Society for Stem Cell Research, who was not involved in the research.

The method, called therapeutic cloning, is one of the great hopes of the stem cell field. It produces stem cells, universal cells that are extracted from embryos, killing the embryos in the process, and, in theory, can be directed to grow into any of the body's cell types. And since the stem cells come from embryos that are clones of individuals, they should be exact genetic matches. Scientists want to obtain such stem cells from patients to study the origin of diseases and to develop replacement cells that would be identical to ones a patient has lost.

Dr. Zon cautioned that "it will take a lot of work" before stem cells fulfill those promises, but said the new finding would bring scientists significantly closer to the goals.

"It will spearhead the effort, for sure," Dr. Zon said.

Until now, scientists have been studying human embryonic stem cells they extracted from embryos that were created for that purpose or from embryos created at fertility clinics and donated by couples who no longer needed them. They also are studying mouse stem cells, working on the extraordinarily difficult task of directing them to develop into specific tissue types.

But researchers wanted embryos that were genetic matches of patients. The only way to do that is to use embryos that were clones of patients. And human cloning had seemed all but impossible.

To produce a clone, scientists slip the genetic material from a patient's cell into an unfertilized egg from another person whose genetic material has been removed. The genes from the patient's cell take over, directing the egg to divide and develop into an embryo that is genetically identical to the patient, rather than the egg donor. About five days later, when the cloned embryo contains about 100 cells, stem cells appear, looking like a ball of cells encased in a sphere.

The process, however, fails more often than it succeeds and in humans it seemed to fail almost all the time. In their previous report, published in February, Dr. Hwang and Dr. Moon used 248 human eggs to produce a single stem cell line.

But this time, with a handful of technical improvements that mostly involved such things as methods for growing cells and breaking open embryos, they used an average of 17 eggs per stem cell line and could almost guarantee success with a single woman's eggs obtained in a single month. And it did not matter if the patient whose cells were being cloned was young or middle aged, male or female, sick or well - the process worked.


"You almost have no reason not to do it," said Dr. Davor Solter, the director of the Max Planck Institute for Immunobiology in Freiberg, Germany.

In fact, Dr. Solter added, it now looks like it is much more efficient to clone and obtain human stem cells than it is to do the same experiment in animals.

Seven states ban cloning for any reason and 11 have laws that prevent embryonic stem cell research, said Lori B. Andrews, a law professor at Chicago-Kent College of Law. And the federal government will not pay for the creation of new stem cell lines. But where such work is legal, increasing numbers of scientists, including Dr. Zon, say they have private financing and plan to go forward using cloning to produce stem cells.

The new paper, said Dr. John Gearhart, a stem cell researcher at Johns Hopkins University, will provide an impetus. "I think you will see more people in the game," he said.

But not everyone is excited.

Dr. Leon Kass, chairman of the President's Council on Bioethics, said in an e-mail message that "whatever its technical merit, this research is morally troubling: it creates human embryos solely for research, makes it much easier to produce cloned babies, and exploits women as egg donors not for their benefit. "

The United States Conference of Catholic Bishops shares those concerns, said Richard Doerflinger, director of pro-life activities there. He added that he also worried that a cloned baby might be next.

"Up until now, people were beginning to wonder whether human cloning for any purpose was feasible at all," Mr. Doerflinger said. "This development makes it feasible enough to be a clear and present danger."


The South Korean study participants wanted only to advance medicine, Dr. Hwang said. They included 18 women who provided eggs, including one of the study's patients, who provided her own eggs. Eleven patients participated - eight adults with spinal cord injuries and three children, consisting of a 10-year-old boy with a spinal cord injury, a 6-year-old girl with diabetes, and a 2-year-old boy with congenital hypogamma-globulinemia, a genetic disorder of the immune system.

Dr. Gerald Schatten of the University of Pittsburgh School of Medicine, who visited the South Korean lab and helped the scientists, whose English is limited, write their paper, said the results were partly the product of extraordinary dedication.

"They work 365 days a year except for leap year, when they work 366 days," Dr. Schatten said. "They have lab meetings at 6:30 every morning except Sunday, when they have them at 8:00."

Scientists say they know the word "cloning" raises fears of actual babies that are clones, but say they have no intention of doing such work. The South Korean government, which paid for the new study, has made it a criminal offense to implant a cloned embryo into a woman's uterus, Dr. Hwang said. "It should be banned throughout the world," he added.

Few would venture into the cloning arena if the science were not so promising, researchers say.

Of course, they add, there is a long way to go from stem cells to therapy. "It's going to take a lot of work," said Dr. Ronald McKay, a stem cell researcher at the National Institutes of Health. "But we want this to work - it's not a theory. My technical and professional judgment tells me this is really important."

But Dr. Kass of the President's Council on Bioethics says that cloning and extracting stem cells from the embryos are not the only ways to do such work. He notes that the majority of the council called for a moratorium on cloning for research. And, he said, the council recently suggested other ways of getting stem cells that could develop into the desired tissue types and that would match a patient's own cells, "without these violations and moral hazards."

Opinion polls have had varied results, often depending on the words that are used to describe the work. In one recent Gallup poll, just 38 percent of respondents approved of cloning embryos for research. Another poll, that used the term "somatic cell nuclear transfer" instead of "cloning" found that 72 percent approved.

Dr. Hwang's paper goes a step further, using "S.C.N.T." instead of "somatic cell nuclear transfer" and then dropping the first two letters and calling the process "N.T."

Some, like Dr. Ruth Faden, the executive director of the bioethics center at Johns Hopkins, say the moral debate will change if stem cell research leads to new treatments with dramatic benefits for some patients. "That could really shake it up," she said.

But Dr. Richard Land, the president of the Southern Baptist Convention's ethics and religious liberty commission, said his group, for one, would not be assuaged.

"We believe a cloned embryo is a human being," he said. "We should not be the kind of society that kills our tiniest human beings in order to seek a treatment for older and bigger human beings."

#284 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 20 May 2005 - 12:44 AM

Thats great news !!! Hopefuly it will change some peoples view on this research. While countries like korea move forward the U.S may be forced to re-consider its stance once it sees the benifits of this research on real living human beings.


"We believe a cloned embryo is a human being"

How is an embryo a human being? Its merely the information for human life, A code that is compiling to create a human being. How could anyone feel sorry for killing a microscopic embryo.

I don't see why there should be this big ethical issue tbh.

When these treatments become available are religious leaders and followers and pro life campaigners going to refuse this sort of treatment when it becomes available to cure their disease?

#285 apocalypse

  • Guest
  • 134 posts
  • 0
  • Location:Diamond sphere

Posted 20 May 2005 - 01:39 AM

Thats great news !!! Hopefuly it will change some peoples view on this research. While countries like korea move forward the U.S may be forced to re-consider its stance once it sees the benifits of this research on real living human beings.


"We believe a cloned embryo is a human being"

How is an embryo a human being?   Its merely the information for human life, A code that is compiling to create a human being. How could anyone feel sorry for killing a microscopic embryo.

I don't see why there should be this big ethical issue tbh.

When these treatments become available are religious leaders and followers and pro life campaigners going to refuse this sort of treatment when it becomes available to cure their disease?


I doubt it, most of them'll be amongst the first to take it.

Their position is ILLOGICAL as we've all seen(biological machinery's just that machinery, without the barest hint of a brain there's no human), and as I've recommended in the past these two arguments should pretty much show them the error of their ways or at least make them accept this kind of work(glad to see many are using the first):

1- Large numbers of human embryos are destroyed by attempts at conception(I've heard figures that indicate that more than half of the time the embryo fails to implant and is flushed/destroyed naturally). This one showcases the illogic of a certain religious group, the catholic. Embrace natural attempts at reproduction and recommend avoiding anticonceptives(maybe they've changed, but that's what I've heard), and at the same time oppose embryo destruction.... yet the formert leads to the latter. In essence it's ok to destroy embryos for the purpose of attempting procreation/pleasure, but it's not ok to do so to treat individuals in need and improve/save many a human life.

2- Simply moding the cell whose nucleus is to be transfered prior to doing so, can make it so that a brain CANNOT develop(the modification's probably feasible with little or no compromisation of the performance of cell's derived from such line.). Maybe even using that new fancy gene therapy technic published in nature(haven't read the paper yet.). Thing is IF A HUMAN BRAIN(or higher portions) CANNOT BE DEVELOPED, It SILENCES THE FINAL ERRONEOUS COUNTER ARGUMENT THEY"VE BEEN USING: 'IT could POTENTIALLY under the right circumstances develop into a human being.". By doing this prior to making the embryo they cannot say "OH you butchered that potential human.". (I'd say that given appropriate highly advanced machinery even simple compounds or even elements could potentially be made into a human given the proper instructions.). Thus by doing this we bypass their erroneous arguments, you cannot DEFEND AN EMBRYO with ILLOGICAL arguments, THAT IS NON-VIABLE FROM the VERY beginning(if they attempt the :" but we could do gene therapy, maybe even HIGHLY advanced gene therapy to go around the faults and make it viable". They'll go down a VERY slippery slope.... they'd face the fact that using highly advanced therapies we could very well turn any cell into a viable embryo, oops you killed millions when you sneezed [lol] . IN fact going further using advanced machinery we could probably turn lumps of cheap materials into one.)

#286 Jay the Avenger

  • Guest
  • 286 posts
  • 3
  • Location:Holland

Posted 20 May 2005 - 10:23 AM

http://news.yahoo.co...e_me/stem_cells

Exponential growth on the march, man... (see bold text in quote below)

By LAURAN NEERGAARD, AP Medical Writer 1 hour, 55 minutes ago

WASHINGTON - South Korean scientists have dramatically sped up the creation of human embryonic stem cells, growing 11 new batches that for the first time were a genetic match for injured or sick patients.

It is a major advancement in the quest to grow patients' own replacement tissue to treat diseases.

The same scientists last year were the first to clone a human embryo. Now they have improved, by more than tenfold, their efficiency at culling these master cells, thus making pursuit of therapeutic cloning more practical.

"I didn't think they would be at this stage for decades, let alone within a year," said Dr. Gerald Schatten of the University of Pittsburgh. He acted as an adviser to the Korean lab in analyzing its data, which was being published Friday in the journal Science.

"This paper will be of major impact," said stem-cell researcher Dr. Rudolph Jaenisch of the Whitehead Institute for Biomedical Research in Cambridge, Mass. "The argument that it will not work in humans will not be tenable after this."

This research is not cloning to make babies. Instead, scientists create test-tube embryos to supply stem cells — the building blocks which give rise to every tissue in the body — that are a genetic match for a particular patient and thus won't be rejected by the immune system.

If scientists could harness the regenerative power of those stem cells, they might be able to repair damage from spinal cord injuries, diabetes, Parkinson's and other diseases.

Stem cells also can come from embryos left over in fertility clinics. But these cells would not be a genetic match for any patient.

Any potential therapy is years away from being tested in people. But the new research marks several advances:

_Last year's cloned stem cells were from one healthy woman. This time, the Seoul scientists created stem cells that were genetic matches to each of 11 patients — male and female, as young as age 2 and as old as 56, suffering either spinal cord injuries, diabetes or a genetic immune disease.

_Last year, it took attempts with 242 donated human eggs to grow one batch of stem cells. This time, it took an average of 17 eggs per batch and 14 eggs if they were from women younger than 30.

_The researchers eliminated use of mouse "feeder cells" that, until now, have been used to nourish human stem-cell lines, easing concerns about animal contamination.

The research also will add to political sparring over whether to expand government-funded stem cell research in the United States.

Because culling stem cells destroys the days-old embryo harboring the cells,
President Bush in 2001 banned federally funded research on all but a few old embryonic stem-cell lines. A vote on whether to ease those restrictions could come in the House as early as next week.

The South Korean research, funded by the South Korean government, spotlights the frustration that many U.S. scientists feel at being left behind.

"It's just going to highlight the tragedy of our current situation in America where there are technologies that are promising that are not being pursued by talented American scientists because of ideologic constraints," said Dr. Janet Rowley of the University of Chicago. The genetics specialist helped write recent national ethics guidelines on stem-cell research.

The lead South Korean researcher, Hwang Woo-suk of Seoul National University, said in a telephone interview, "Therapeutic cloning has tremendous, tremendous healing potential, but we have to open so many doors before human trials."

More immediately, the research will allow scientists to watch the very earliest origins of diseases such as Alzheimer's form inside an actual patient's cloned, living cells, said neuroscientist Fred Gage of the Salk Institute for Biological Studies in San Diego. That could point to new ways to prevent and treat illness, said Gage, who plans to perform some of that work.

The Seoul researchers collected eggs that were donated by 18 unpaid volunteers and removed the gene-containing nucleus from them.

The scientists inserted into those eggs DNA from skin cells of the 11 patients and chemically jump-started cellular division. Thirty-one blastocysts — early-stage embryos of 100 or so cells each — successfully grew. From those, the scientists harvested 11 stem cell lines.

Each is a genetic match to the patient who had donated a skin snippet, and each can form other tissues, such as brain cells or bone cells. Next, the scientists must learn how to control that cell development.

The work means there may be more demand for donated eggs for medical research. Women considering doing so must understand they get no benefit and face some risk, said Stanford University bioethicists David Magnus and Mildred Cho.

The advances do not mean it is time to try reproductive cloning, Hwang said. That, he said, "is unsafe and unethical," noting that animal studies show more failures than successes. "Biologically, it may be impossible."

___

On the Net:

Science: http://www.sciencemag.org



#287 Lazarus Long

  • Life Member, Guardian
  • 8,116 posts
  • 242
  • Location:Northern, Western Hemisphere of Earth, Usually of late, New York

Posted 20 May 2005 - 06:05 PM

And see what happens when you don't read the memos.

http://story.news.ya...emcells_bush_dc

Bush would veto House bill on stem cells
By Steve Holland
2 hours, 25 minutes ago

WASHINGTON (Reuters) - President Bush said on Friday he would veto legislation that would loosen restrictions on embryonic stem cell research and expressed concern about human cloning research in South Korea.

In the House of Representatives, supporters of embryonic research sponsored by Republican Rep. Mike Castle of Delaware and Democratic Rep. Diane DeGette of Colorado hope for a vote next week and believe it will be close.

Bush said the bill would violate his principles.

"I've made it very clear to the Congress that the use of federal money, taxpayers' money, to promote science which destroys life in order to save life -- I'm against that. And therefore if the bill does that, I will veto it," Bush told reporters during a picture-taking session with Danish Prime Minister Anders Fogh Rasmussen.

He also said he was concerned by a report today from South Korean scientists that they are developing a cloning process that would produce human embryos that could then serve as the source of stem cells for medical and scientific uses.

"I'm very concerned about cloning," the president said. "I worry about a world in which cloning becomes acceptable."

{excerpt}

#288 manofsan

  • Guest
  • 1,223 posts
  • 56

Posted 21 May 2005 - 05:50 AM

Well, maybe the Koreans will give us Moore's Law on stem cell advancement. ;P

#289 kevin

  • Member, Guardian
  • 2,779 posts
  • 822

Posted 21 May 2005 - 06:42 AM

Link: http://www.guardian.....html?gusrc=rss


Posted Image
DNA pioneer accuses Britain over slow pace of stem cell research

Sam Jones
Saturday May 21, 2005
The Guardian


James Watson, the biologist who won a Nobel Prize for unravelling the secrets of DNA with Francis Crick in 1953, has launched a scathing attack on Britain for its "piss poor" approach to stem cell research.

The scientist described Britain as a "bit player" in the field and said the country would continue to lag behind the rest of the world if the government did not dramatically increase the £40m it currently spends on stem cell research.

In a candid talk at the Science Museum in London last night, Dr Watson questioned the UK's commitment to new genetic research that could yield treatments for degenerative diseases such as Parkinson's and Alzheimer's.

"I think there should be some urgency and I must say I detect in England no urgency at all," he said. "It is much more important what happens to Manchester United - that seems to be the only urgency situation in the UK. Priorities are a little wrong."

His comments came a day after researchers at Newcastle University said they had cloned a human embryo for the first time in Britain.

Their announcement coincided with the news that South Korean scientists had created stem cells tailored to patients with specific illnesses.

Urging the government to raise its stem cell research budget, he said: "You want to be in the same league as the Koreans, but do you want to be a big player? Rather now, you are a bit player."

Dr Watson said he had not been particularly stunned by news of the Newcastle team's achievement, but said they still needed more support.

"I wasn't very surprised," he said. "It is nice science, but they should just be doing it faster. I met them in Newcastle. You have one post doc[toral researcher] - there should be a group 10 times the size. You are not doing it on a level to have a real impact on the world or on science.


"Most of Europe is doing nothing. Britain has said they are doing something, but they are going about it in a piss poor fashion."

He also used the discussion to dismiss moral objections to stem cell research. The 77-year-old American said he did not believe sperm had a soul, and added that religious arguments over the new technology seemed "rather false piety".

He has been a vociferous advocate of stem cell research despite the controversy and stringent regulations it has attracted in the US.

President George Bush was accused of caving in to anti-abortion groups when he limited federal funding of embryonic stem cell research to only the 78 stem cell lines in existence before August 2001.

Mr Bush made his position on the issue even clearer yesterday when he said he would veto legislation currently nearing fruition on Capitol Hill that would allow more government funding of stem cell research. He said he was against "the use of federal money, taxpayers' money, to promote science which destroys life in order to save life."

Mr Bush has never used his veto power.

Dr Watson was 24 when he and Francis Crick realised that the DNA molecule resembled a twisted ladder, or "double helix", while working at Cambridge University in 1953. They were awarded the Nobel prize for medicine in 1962.

#290 Lazarus Long

  • Life Member, Guardian
  • 8,116 posts
  • 242
  • Location:Northern, Western Hemisphere of Earth, Usually of late, New York

Posted 22 May 2005 - 11:03 PM

Here is an example not merely of the importance of Federal funding but its efficiency and effectiveness as *moral* support. The President and his group are not willing to debate ethics that they believe are immutable and unquestionable, IOW absolute.

http://story.news.ya...mcells_hwang_dc

Korean stem cell study funded on $200,000 a year

By Kim Yoo-chul
Fri May 20, 8:08 AM ET

SEOUL (Reuters) - A groundbreaking study on stem cell research that could one day provide a cure for debilitating illnesses was funded with less than $200,000 a year in largely government grants, a South Korean scientist said on Friday.

Woo Suk Hwang of Seoul National University and his South Korean team announced on Thursday that they had successfully created batches of embryonic stem cells from patients.

Their study fulfils one of the basic promises of using cloning technology in stem cell research -- that a piece of skin could be taken from a patient and used to grow the cells.

Researchers believe the cells could be trained to provide tailored tissue and transplant organs to cure juvenile diabetes, Parkinson's disease and even to repair severed spinal cords.

Hwang said that about $2 million in funds available to him this year is shared by 20 teams conducting various research projects under his supervision.

"The cost that actually went into stem cell research would be about a tenth of the amount," he told reporters after arriving home from London.

The cost was equivalent to about one hundredth of the funds that scientists in the United States work with on similar projects, said Park Ky-young, South Korea's presidential adviser for information, science and technology.

Hwang said his team would begin looking at opportunities in international cooperation to fund his study but it could pose further ethical challenges.
{excerpt}

#291 Lazarus Long

  • Life Member, Guardian
  • 8,116 posts
  • 242
  • Location:Northern, Western Hemisphere of Earth, Usually of late, New York

Posted 23 May 2005 - 03:34 PM

A little constructive East/West friendly rivalry?

Posted Image
http://www.nytimes.c...ion/23stem.html
3 NY City Institutions to Get $50 Million for Stem Cell Research
By RICHARD PÉREZ-PEÑA
Published: May 23, 2005

As debates over embryonic stem cell research flare anew worldwide, a private foundation says it will give $50 million for such work to three Upper East Side medical institutions, a gift they say will position New York City as a player in an increasingly competitive field.

The Starr Foundation plans to give the money over three years to Weill Medical College of Cornell University, Rockefeller University and Memorial Sloan-Kettering Cancer Center, which will collaborate on research projects. The recipients say it is among the 10 biggest gifts - and the second largest dedicated to research - ever received by any of the three institutions.

"We face a very serious threat of losing economically, losing our scientific leadership, and even losing our top scientists, as other countries and California race ahead in this crucial field," said Dr. Antonio M. Gotto, dean of Weill Cornell. "A gift like this helps keep New York and the United States competitive."

The three institutions each have scientists doing stem cell work in fields like the origins of leukemia or the development of skin, blood and nerve tissue, but they have very different approaches to medicine.

Rockefeller concentrates more on research into fundamental questions of biology and disease than on treating patients. Sloan-Kettering has the most specific focus, on cancer, in both research and clinical treatment. Weill, as a major medical school attached to a large teaching hospital, has the broadest focus, and it has one of the world's largest fertility clinics, ensuring a ready supply of frozen embryos that can yield stem cells.

****

Other nations have increased their support for embryonic stem cell research, and members of Congress have debated ways to ease the president's ban. Scientists have announced ethical boundaries. Californians voted to devote $3 billion in state money to the field - though that remains stalled - and New York and a few states have considered following California's lead, while still other states have outlawed all embryonic stem cell research.

Private groups like the Juvenile Diabetes Research Foundation and philanthropic foundations have also devoted increasing sums of money to stem cell research. With the Starr Foundation's $50 million gift, "New York institutions have attracted something in the range of $100 million in philanthropy in the last year for stem cell research," said Harold E. Varmus, president of Sloan-Kettering. "But I don't think it can fully take the place of federal funding."

{excerpts)

#292 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 23 May 2005 - 06:39 PM

Hwang Starts Gathering Stem Cell 'Dream Team'

Posted Image

Prof. Hwang Woo-suk’s successes in embryonic stem cell research are changing the face of the field, and international experts are queuing up to work with him. Hwang has announced he hopes to put together an international “dream team” to streamline research into what could be our best hope to cure incurable diseases.
Hwang’s team is to be picked from top research centers in different areas such as stem cell safety, animal testing and clinical trials needed to advance the practical use of stem cell research.

Hwang’s team is to be picked from top research centers in different areas such as stem cell safety, animal testing and clinical trials needed to advance the practical use of stem cell research.

To ensure safety, it appears Cambridge University’s stem cell genetic analysis specialist Roger Pedersen and Johns Hopkins University’s Curt Civin, a specialist in cellular transformations resulting from stem cell transplants, will take part in joint research.

For primate testing, which is the stage before clinical testing on humans, Hwang has joined forces with the University of Pittsburgh’s Prof. Gerald P. Schatten, who co-wrote Dr. Hwang’s groundbreaking article for Science that made headlines last week. Two researchers with Hwang’s team, including Dr. Park Jong-won, were sent to Pittsburgh last year.
Spinal cord injuries and nervous disorders like Alzheimer's and Lou Gehrig’s disease and diabetes are expected to be among the first diseases where stem cell treatment will be tried, because with these disorders there is hope of a complete cure if only one group of cells, be it nerve cells or insulin secretion cells, can be replaced.


For clinical tests on nervous disorders, Hwang’s team has entered into an agreement with the Dr. Ian Wilmut of the U.K.’s Roslin Institute, who cloned Dolly the sheep. If Hwang is able to create embryonic stem cell from patients of Lou Gehrig’s Disease, Wilmut would take the cells and research patient transplants. Nerve cell specialist Lorenz Studer of New York’s Memorial Sloan-Kettering Cancer Center would be expected to head research with Alzheimer's disease.

For diabetes research, Harvard University Medical School’s Dr. Douglas Melton appears to be a strong candidate. Melton’s team has the most surplus embryonic stem cells in the U.S., and is conducting research on juvenile diabetes. Both of Melton’s children are afflicted with juvenile diabetes, so he is particularly keen on joint research.

“From now on, with basic stem cell research completed, the time until such research can be used practically will depend on how and with whom it is conducted,” Hwang said. “We plan to include as many domestic research teams as possible.”

http://english.chosu...0505230027.html

#293 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 26 May 2005 - 04:25 AM

If this breakthrough has really happend we should hear more in the coming days. Progress is quite fast these days hu?

South Korea’s stem cell kings may have been dethroned

WITH great fanfare a South Korean team announced last week that it had used therapeutic cloning to create human embryonic stem cells that were genetically matched to specific people. But their technique could already be obsolete.

Another team headed by Yuri Verlinsky of the Reproductive Genetics Institute, based in Chicago, claims to have produced patient-matched embryonic stem cells without resorting to therapeutic cloning. "It would be a much better approach," he says.

Verlinsky says he has already created 10 embryonic stem cell (ESC) lines using his new "stembrid" technique. Unlike therapeutic cloning, it uses existing ESCs instead of human eggs, and so would be much cheaper and easier. What's more, because no embryos are destroyed, it would bypass many ethical issues.

"If it is as he said, it would be spectacular," says Jacques Cohen of Tyho-Galileo Research Laboratories, who has been investigating alternative sources of ESCs. But he and other experts say Verlinsky must do a lot more work to prove his claim.

While ESCs show great promise for treating many diseases, such as heart disease, diabetes and Parkinson's, non-matching ESCs would be rejected by patients' immune systems unless they take immunosuppressant drugs. This is why many stem cell researchers are trying to create ESCs that are identical to people's own cells.

More here http://www.newscient...=mg18625014.100



#294 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 01 June 2005 - 12:49 AM

Research boosts hope for stem cell therapy
Wednesday June 1, 2005

'Stress testing' dispels fear of dangerous instability

Cambridge scientists believe that they have settled another doubt about embryo stem cell therapy, the controversial technique that could offer new hope for people with diabetes, Parkinson's disease or even spinal injury.
They report today in Nature Genetics that human embryo stem cells seem stable and unlikely to be altered in any dangerous way as they develop.

Stem cells are the agents that in 40 weeks turn a fertilised egg into a human being composed of 100 trillion cells of more than 200 different kinds. Two weeks ago South Korean scientists used the science developed to produce Dolly the sheep to "clone" embryo stem cells from 11 patients suffering from a range of injuries and inherited diseases, in the hope that one day they might be able to use them for "personalised" tissue transplants.

But experiments with mouse embryo stem cells had raised a worry: would the complex chemical machinery of development in some way trigger damaging genetic changes in laboratory-grown human stem cells? If so, they would not be safe for transplantation.
Peter Rugg-Gunn, Anne Ferguson-Smith and Roger Pedersen of the Cambridge Stem Cell Institute looked at the set of factors called "epigenetic" regulation: the still-mysterious forces beyond DNA that make a gene do what it should, when it should, during growth and development.

If DNA is the keyboard of an organ, then the epigenetic factors are the pedals, the stops, the organist's hands and even the lid: they influence how things happen, or whether they happen at all.

The scientists focused on the regulation of six "imprinted genes", so called because their expression depends on whether they are inherited from either the mother or the father, but not both. They could not detect any worrying alterations in cells grown in laboratory culture.

The research was the biological equivalent of factory stress tests.

"Like you'd slam the door of a car thousands of times to find out if it was the hinges or the latch that wore out first," Prof Pedersen said. "The question is how much can we stress these cells? Can we reveal any weakness in the system? In any cultured cell, if you stress it enough, you can eventually find that - like a part in a machine - something will wear down or break down and it is very interesting to see what that is, because it tells you something about, in this case, biology."

Prof Pedersen is a Californian scientist who shifted to Cambridge to pursue work on embryo stem cells. The US government will not allow such research using federal funds, and privately funded research is unregulated. However, Britain, after two years of debate, authorised embryo stem cell research in 2001. The dream is that "personalised" insulin-producing cells, brain cells or spinal cord cells could be injected into patients with diabetes, Parkinson's disease or spinal injury, to replace lost tissue. But huge questions of safety and efficacy must first be settled.

"As an advocate myself of the therapeutic use of these cells," said Prof Pedersen, "I couldn't sleep at night if I hadn't done this study. What we are trying to do is undertake the development of human cells, the recapitulation of early human development, in a Petri dish.

"That has never been done before. Therefore, there is no assurance from any pre-existing study, or knowledge, that what comes out of that is going to be normal, is going to be correct. So how do we investigate that? We can't and won't make humans in the test tube, obviously."

#295

  • Lurker
  • 1

Posted 19 June 2005 - 02:27 AM

Congratulations to Professor Hwang.

The technique

Stem cells are primitive "master" cells that can be programmed to become many kinds of tissue.

To make them patient-specific, the researchers took DNA from the skin cells of volunteers and put this genetic material into donated human eggs which had had their own genetic material removed.

These eggs were grown to a very early stage of embryo development, around six days, when they were still just small balls of cells. The scientists then extracted the stem cells.

When the researchers examined them in the laboratory, the stem cells appeared to be immunologically compatible to the individual who donated the DNA.

Professor Chris Higgins, from the UK Medical Research Council, said: "It really is an advance. It offers the possibility of stem cell therapies without rejection.

"Also, the scientists have improved their technique and reliability of stem cell transfer."

Professor Ian Wilmut, from the Roslin Institute in Edinburgh and creator of Dolly the sheep, said: "These new observations make a very significant and important step forward toward the use of cells from cloned human embryos for research and therapy."

Roger Pedersen, Professor of Regenerative Medicine, University of Cambridge, said the work provided "ample evidence" for the feasibility of replacing the genome of a human egg with that of an adult body cell.

And Professor Alison Murdoch, Chair of the British Fertility Society, and Dr Miodrag Stojkovic, Deputy Director of Centre for Stem Cell Biology and Developmental Genetics in Newcastle, said: "We are delighted.

"The promise of new treatments based on stem cell technology is moving nearer to becoming a realistic possibility."


see attached Science paper published 17 June 2005

Edited by Bates, 23 July 2005 - 07:08 PM.


#296 Chip

  • Guest
  • 387 posts
  • 0

Posted 19 June 2005 - 03:28 AM

I don't know. Sure seems to me like there a lot of potentials in many fields. Will we develop them for the welfare of our life or stick to our guns? I don't know.

#297

  • Lurker
  • 1

Posted 18 August 2005 - 05:04 AM

Mesenchymal stem cells do not evoke graft versus host disease:

J Inflamm (Lond). 2005 Jul 26;2(1):8
Mesenchymal stem cells avoid allogeneic rejection.
Ryan JM, Barry FP, Murphy JM, Mahon BP.

http://www.journal-i...76-9255-2-8.pdf

#298 judas

  • Guest
  • 12 posts
  • 0

Posted 22 August 2005 - 01:33 PM

Hope this is the right place to post this.

It appears some scientists at Harvard might be close to sidestepping the whole moral/ethical entanglements of regular stem cell production by coaxing skin cells to become stem cells.

Yahoo Story

-Judas

#299 Lazarus Long

  • Life Member, Guardian
  • 8,116 posts
  • 242
  • Location:Northern, Western Hemisphere of Earth, Usually of late, New York

Posted 24 August 2005 - 01:26 PM

More vitally important specialized tissues have been reproduced. I hope we can share this article soon.

http://news.yahoo.co...sintolungtissue

Beakthrough Work Converts Stem Cells into Lung Tissue

Robert Roy Britt
LiveScience Managing Editor, LiveScience.com
Tue Aug 23,12:00 PM ET

Scientists have converted human embryonic stem cells into lung cells, taking an initial step towards building human lungs for transplantation.

While the actual lab construction of lungs is surely a far-off project, scientists are excited about their ability to control the development of cells. Some medical applications could be right around the corner.

Stem cells are special cells that transform into the various types of cells needed to make a living body. Embryonic stem cells are able to make the bone, muscle, blood and all other tissue from which we're all made.

Other groups have used stem cells in labs to make mouse sperm and human brain neurons.

Now scientists at Imperial College London have taken human embryonic stem cells and guided their conversion into the type of cell needed for gas exchange in the lung, known as mature small airway epithelium.

"This is a very exciting development, and could be a huge step towards being able to build human lungs for transplantation or to repair lungs severely damaged by incurable diseases such as cancer," said study leader Julia Polak.

The results will be published in the journal Tissue Engineering.

"Although it will be some years before we are able to build actual human lungs for transplantation, this is a major step towards deriving cells that could be used to repair damaged lungs," said fellow researcher Anne Bishop of the college.

In the near term, the breakthrough could help treat acute respiratory distress syndrome (ARDS), which causes the lining of the cells to fall off. By injecting stem cells that will become lung cells, the scientists hope to be able to repair the lung lining.

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#300 Omnido

  • Guest
  • 194 posts
  • 2

Posted 24 August 2005 - 07:47 PM

All steps in the correct direction. Give it time. Soon, all 200+ types of cells will be developed in a simialr fashion, and not too long after that, organized into specific tissue types and structures.

Bravo.




0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users